nodes	percent_of_prediction	percent_of_DWPC	metapath
Esomeprazole—Barrett's esophagus—stomach cancer	0.836	1	CtDrD
Esomeprazole—ATP4A—gastric juice—stomach cancer	0.0249	0.549	CbGeAlD
Esomeprazole—ATP4B—digestive system—stomach cancer	0.00349	0.0769	CbGeAlD
Esomeprazole—ATP4B—endocrine gland—stomach cancer	0.00288	0.0636	CbGeAlD
Esomeprazole—ATP4B—liver—stomach cancer	0.0026	0.0573	CbGeAlD
Esomeprazole—ATP4A—Secretion of Hydrochloric Acid in Parietal Cells—GAST—stomach cancer	0.00235	0.431	CbGpPWpGaD
Esomeprazole—ATP4A—hematopoietic system—stomach cancer	0.00219	0.0482	CbGeAlD
Esomeprazole—ATP4A—epithelium—stomach cancer	0.002	0.044	CbGeAlD
Esomeprazole—ATP4A—digestive system—stomach cancer	0.00152	0.0335	CbGeAlD
Esomeprazole—ATP4A—endocrine gland—stomach cancer	0.00126	0.0277	CbGeAlD
Esomeprazole—ATP4A—liver—stomach cancer	0.00113	0.025	CbGeAlD
Esomeprazole—CYP2C19—hematopoietic system—stomach cancer	0.000763	0.0168	CbGeAlD
Esomeprazole—CYP2C19—digestive system—stomach cancer	0.000531	0.0117	CbGeAlD
Esomeprazole—CYP3A4—hematopoietic system—stomach cancer	0.000451	0.00995	CbGeAlD
Esomeprazole—CYP2C19—endocrine gland—stomach cancer	0.000439	0.00967	CbGeAlD
Esomeprazole—ATP4B—Ion channel transport—CLCN3—stomach cancer	0.000436	0.0799	CbGpPWpGaD
Esomeprazole—CYP2C19—liver—stomach cancer	0.000395	0.00872	CbGeAlD
Esomeprazole—ATP4A—Ion channel transport—CLCN3—stomach cancer	0.000389	0.0712	CbGpPWpGaD
Esomeprazole—CYP3A4—digestive system—stomach cancer	0.000314	0.00692	CbGeAlD
Esomeprazole—CYP3A4—endocrine gland—stomach cancer	0.000259	0.00572	CbGeAlD
Esomeprazole—CYP3A4—liver—stomach cancer	0.000234	0.00515	CbGeAlD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000152	0.0278	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000135	0.0248	CbGpPWpGaD
Esomeprazole—CYP2C19—CYP2E1 reactions—CYP2A6—stomach cancer	0.000123	0.0225	CbGpPWpGaD
Esomeprazole—CYP2C19—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	0.000106	0.0194	CbGpPWpGaD
Esomeprazole—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—stomach cancer	8.42e-05	0.0154	CbGpPWpGaD
Esomeprazole—CYP2C19—Xenobiotics—CYP2A6—stomach cancer	7.6e-05	0.0139	CbGpPWpGaD
Esomeprazole—CYP2C19—Tamoxifen metabolism—CYP2A6—stomach cancer	7.31e-05	0.0134	CbGpPWpGaD
Esomeprazole—CYP3A4—Aflatoxin B1 metabolism—GSTM1—stomach cancer	6.82e-05	0.0125	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—SLC1A2—stomach cancer	6.6e-05	0.0121	CbGpPWpGaD
Esomeprazole—CYP3A4—Constitutive Androstane Receptor Pathway—PPP2R4—stomach cancer	6.35e-05	0.0116	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—SLC1A2—stomach cancer	5.89e-05	0.0108	CbGpPWpGaD
Esomeprazole—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—stomach cancer	5.46e-05	0.01	CbGpPWpGaD
Esomeprazole—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	5.22e-05	0.00956	CbGpPWpGaD
Esomeprazole—CYP2C19—Melatonin metabolism and effects—ADRB1—stomach cancer	5.08e-05	0.00931	CbGpPWpGaD
Esomeprazole—Alopecia—Methotrexate—stomach cancer	4.81e-05	0.000425	CcSEcCtD
Esomeprazole—Bradycardia—Doxorubicin—stomach cancer	4.8e-05	0.000424	CcSEcCtD
Esomeprazole—Dyspnoea—Docetaxel—stomach cancer	4.79e-05	0.000423	CcSEcCtD
Esomeprazole—Somnolence—Docetaxel—stomach cancer	4.77e-05	0.000422	CcSEcCtD
Esomeprazole—Mental disorder—Methotrexate—stomach cancer	4.77e-05	0.000421	CcSEcCtD
Esomeprazole—Eye disorder—Epirubicin—stomach cancer	4.76e-05	0.000421	CcSEcCtD
Esomeprazole—Tinnitus—Epirubicin—stomach cancer	4.75e-05	0.00042	CcSEcCtD
Esomeprazole—Malnutrition—Methotrexate—stomach cancer	4.74e-05	0.000419	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Capecitabine—stomach cancer	4.74e-05	0.000418	CcSEcCtD
Esomeprazole—Flushing—Epirubicin—stomach cancer	4.73e-05	0.000418	CcSEcCtD
Esomeprazole—Vomiting—Fluorouracil—stomach cancer	4.73e-05	0.000418	CcSEcCtD
Esomeprazole—Rhinitis—Doxorubicin—stomach cancer	4.73e-05	0.000418	CcSEcCtD
Esomeprazole—Dyspepsia—Docetaxel—stomach cancer	4.73e-05	0.000417	CcSEcCtD
Esomeprazole—Hepatitis—Doxorubicin—stomach cancer	4.72e-05	0.000417	CcSEcCtD
Esomeprazole—Insomnia—Capecitabine—stomach cancer	4.7e-05	0.000415	CcSEcCtD
Esomeprazole—Hypoaesthesia—Doxorubicin—stomach cancer	4.69e-05	0.000414	CcSEcCtD
Esomeprazole—Rash—Fluorouracil—stomach cancer	4.69e-05	0.000414	CcSEcCtD
Esomeprazole—Dermatitis—Fluorouracil—stomach cancer	4.69e-05	0.000414	CcSEcCtD
Esomeprazole—Pharyngitis—Doxorubicin—stomach cancer	4.68e-05	0.000413	CcSEcCtD
Esomeprazole—Paraesthesia—Capecitabine—stomach cancer	4.67e-05	0.000412	CcSEcCtD
Esomeprazole—Decreased appetite—Docetaxel—stomach cancer	4.67e-05	0.000412	CcSEcCtD
Esomeprazole—Headache—Fluorouracil—stomach cancer	4.66e-05	0.000412	CcSEcCtD
Esomeprazole—Urinary tract disorder—Doxorubicin—stomach cancer	4.66e-05	0.000411	CcSEcCtD
Esomeprazole—Oedema peripheral—Doxorubicin—stomach cancer	4.65e-05	0.00041	CcSEcCtD
Esomeprazole—Dysgeusia—Methotrexate—stomach cancer	4.64e-05	0.00041	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Docetaxel—stomach cancer	4.64e-05	0.000409	CcSEcCtD
Esomeprazole—Connective tissue disorder—Doxorubicin—stomach cancer	4.64e-05	0.000409	CcSEcCtD
Esomeprazole—Dyspnoea—Capecitabine—stomach cancer	4.64e-05	0.000409	CcSEcCtD
Esomeprazole—Fatigue—Docetaxel—stomach cancer	4.63e-05	0.000409	CcSEcCtD
Esomeprazole—Urethral disorder—Doxorubicin—stomach cancer	4.62e-05	0.000408	CcSEcCtD
Esomeprazole—Nausea—Irinotecan—stomach cancer	4.61e-05	0.000407	CcSEcCtD
Esomeprazole—Immune system disorder—Epirubicin—stomach cancer	4.6e-05	0.000407	CcSEcCtD
Esomeprazole—Mediastinal disorder—Epirubicin—stomach cancer	4.59e-05	0.000406	CcSEcCtD
Esomeprazole—Constipation—Docetaxel—stomach cancer	4.59e-05	0.000406	CcSEcCtD
Esomeprazole—Pain—Docetaxel—stomach cancer	4.59e-05	0.000406	CcSEcCtD
Esomeprazole—Back pain—Methotrexate—stomach cancer	4.59e-05	0.000405	CcSEcCtD
Esomeprazole—Dyspepsia—Capecitabine—stomach cancer	4.58e-05	0.000404	CcSEcCtD
Esomeprazole—Chills—Epirubicin—stomach cancer	4.57e-05	0.000404	CcSEcCtD
Esomeprazole—CYP3A4—Xenobiotics—CYP2A6—stomach cancer	4.57e-05	0.00837	CbGpPWpGaD
Esomeprazole—Visual impairment—Doxorubicin—stomach cancer	4.55e-05	0.000401	CcSEcCtD
Esomeprazole—Decreased appetite—Capecitabine—stomach cancer	4.52e-05	0.000399	CcSEcCtD
Esomeprazole—Alopecia—Epirubicin—stomach cancer	4.51e-05	0.000398	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Capecitabine—stomach cancer	4.49e-05	0.000396	CcSEcCtD
Esomeprazole—Fatigue—Capecitabine—stomach cancer	4.48e-05	0.000396	CcSEcCtD
Esomeprazole—Vision blurred—Methotrexate—stomach cancer	4.47e-05	0.000395	CcSEcCtD
Esomeprazole—Mental disorder—Epirubicin—stomach cancer	4.47e-05	0.000394	CcSEcCtD
Esomeprazole—Erythema multiforme—Doxorubicin—stomach cancer	4.46e-05	0.000394	CcSEcCtD
Esomeprazole—Pain—Capecitabine—stomach cancer	4.45e-05	0.000393	CcSEcCtD
Esomeprazole—Constipation—Capecitabine—stomach cancer	4.45e-05	0.000393	CcSEcCtD
Esomeprazole—Malnutrition—Epirubicin—stomach cancer	4.44e-05	0.000392	CcSEcCtD
Esomeprazole—Feeling abnormal—Docetaxel—stomach cancer	4.43e-05	0.000391	CcSEcCtD
Esomeprazole—Nausea—Fluorouracil—stomach cancer	4.42e-05	0.00039	CcSEcCtD
Esomeprazole—Eye disorder—Doxorubicin—stomach cancer	4.41e-05	0.000389	CcSEcCtD
Esomeprazole—Ill-defined disorder—Methotrexate—stomach cancer	4.4e-05	0.000389	CcSEcCtD
Esomeprazole—Tinnitus—Doxorubicin—stomach cancer	4.4e-05	0.000388	CcSEcCtD
Esomeprazole—CYP3A4—Tamoxifen metabolism—CYP2A6—stomach cancer	4.39e-05	0.00805	CbGpPWpGaD
Esomeprazole—Gastrointestinal pain—Docetaxel—stomach cancer	4.39e-05	0.000388	CcSEcCtD
Esomeprazole—Anaemia—Methotrexate—stomach cancer	4.38e-05	0.000387	CcSEcCtD
Esomeprazole—Flushing—Doxorubicin—stomach cancer	4.38e-05	0.000387	CcSEcCtD
Esomeprazole—Flatulence—Epirubicin—stomach cancer	4.37e-05	0.000386	CcSEcCtD
Esomeprazole—Tension—Epirubicin—stomach cancer	4.36e-05	0.000385	CcSEcCtD
Esomeprazole—Dysgeusia—Epirubicin—stomach cancer	4.35e-05	0.000384	CcSEcCtD
Esomeprazole—Nervousness—Epirubicin—stomach cancer	4.31e-05	0.000381	CcSEcCtD
Esomeprazole—Back pain—Epirubicin—stomach cancer	4.29e-05	0.000379	CcSEcCtD
Esomeprazole—Feeling abnormal—Capecitabine—stomach cancer	4.28e-05	0.000378	CcSEcCtD
Esomeprazole—Malaise—Methotrexate—stomach cancer	4.28e-05	0.000378	CcSEcCtD
Esomeprazole—Muscle spasms—Epirubicin—stomach cancer	4.27e-05	0.000377	CcSEcCtD
Esomeprazole—Immune system disorder—Doxorubicin—stomach cancer	4.26e-05	0.000376	CcSEcCtD
Esomeprazole—Vertigo—Methotrexate—stomach cancer	4.26e-05	0.000376	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Capecitabine—stomach cancer	4.25e-05	0.000375	CcSEcCtD
Esomeprazole—Mediastinal disorder—Doxorubicin—stomach cancer	4.25e-05	0.000375	CcSEcCtD
Esomeprazole—Body temperature increased—Docetaxel—stomach cancer	4.25e-05	0.000375	CcSEcCtD
Esomeprazole—Abdominal pain—Docetaxel—stomach cancer	4.25e-05	0.000375	CcSEcCtD
Esomeprazole—Leukopenia—Methotrexate—stomach cancer	4.25e-05	0.000375	CcSEcCtD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—ALOX5—stomach cancer	4.24e-05	0.00778	CbGpPWpGaD
Esomeprazole—Chills—Doxorubicin—stomach cancer	4.23e-05	0.000374	CcSEcCtD
Esomeprazole—Vision blurred—Epirubicin—stomach cancer	4.18e-05	0.000369	CcSEcCtD
Esomeprazole—Alopecia—Doxorubicin—stomach cancer	4.17e-05	0.000368	CcSEcCtD
Esomeprazole—Cough—Methotrexate—stomach cancer	4.14e-05	0.000365	CcSEcCtD
Esomeprazole—Mental disorder—Doxorubicin—stomach cancer	4.13e-05	0.000365	CcSEcCtD
Esomeprazole—Urticaria—Capecitabine—stomach cancer	4.13e-05	0.000365	CcSEcCtD
Esomeprazole—Ill-defined disorder—Epirubicin—stomach cancer	4.12e-05	0.000364	CcSEcCtD
Esomeprazole—Abdominal pain—Capecitabine—stomach cancer	4.11e-05	0.000363	CcSEcCtD
Esomeprazole—Body temperature increased—Capecitabine—stomach cancer	4.11e-05	0.000363	CcSEcCtD
Esomeprazole—Malnutrition—Doxorubicin—stomach cancer	4.11e-05	0.000363	CcSEcCtD
Esomeprazole—Anaemia—Epirubicin—stomach cancer	4.1e-05	0.000362	CcSEcCtD
Esomeprazole—Agitation—Epirubicin—stomach cancer	4.08e-05	0.00036	CcSEcCtD
Esomeprazole—Flatulence—Doxorubicin—stomach cancer	4.05e-05	0.000357	CcSEcCtD
Esomeprazole—Chest pain—Methotrexate—stomach cancer	4.04e-05	0.000357	CcSEcCtD
Esomeprazole—Arthralgia—Methotrexate—stomach cancer	4.04e-05	0.000357	CcSEcCtD
Esomeprazole—Myalgia—Methotrexate—stomach cancer	4.04e-05	0.000357	CcSEcCtD
Esomeprazole—Tension—Doxorubicin—stomach cancer	4.03e-05	0.000356	CcSEcCtD
Esomeprazole—Dysgeusia—Doxorubicin—stomach cancer	4.02e-05	0.000355	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	4.01e-05	0.000354	CcSEcCtD
Esomeprazole—Malaise—Epirubicin—stomach cancer	4e-05	0.000353	CcSEcCtD
Esomeprazole—Discomfort—Methotrexate—stomach cancer	3.99e-05	0.000352	CcSEcCtD
Esomeprazole—Nervousness—Doxorubicin—stomach cancer	3.99e-05	0.000352	CcSEcCtD
Esomeprazole—Vertigo—Epirubicin—stomach cancer	3.99e-05	0.000352	CcSEcCtD
Esomeprazole—Leukopenia—Epirubicin—stomach cancer	3.97e-05	0.000351	CcSEcCtD
Esomeprazole—Back pain—Doxorubicin—stomach cancer	3.97e-05	0.000351	CcSEcCtD
Esomeprazole—Hypersensitivity—Docetaxel—stomach cancer	3.96e-05	0.000349	CcSEcCtD
Esomeprazole—Muscle spasms—Doxorubicin—stomach cancer	3.95e-05	0.000349	CcSEcCtD
Esomeprazole—Palpitations—Epirubicin—stomach cancer	3.92e-05	0.000346	CcSEcCtD
Esomeprazole—Confusional state—Methotrexate—stomach cancer	3.9e-05	0.000345	CcSEcCtD
Esomeprazole—Cough—Epirubicin—stomach cancer	3.87e-05	0.000342	CcSEcCtD
Esomeprazole—Anaphylactic shock—Methotrexate—stomach cancer	3.87e-05	0.000342	CcSEcCtD
Esomeprazole—Vision blurred—Doxorubicin—stomach cancer	3.87e-05	0.000342	CcSEcCtD
Esomeprazole—Asthenia—Docetaxel—stomach cancer	3.85e-05	0.00034	CcSEcCtD
Esomeprazole—Infection—Methotrexate—stomach cancer	3.85e-05	0.00034	CcSEcCtD
Esomeprazole—Hypertension—Epirubicin—stomach cancer	3.83e-05	0.000338	CcSEcCtD
Esomeprazole—Hypersensitivity—Capecitabine—stomach cancer	3.83e-05	0.000338	CcSEcCtD
Esomeprazole—Ill-defined disorder—Doxorubicin—stomach cancer	3.81e-05	0.000336	CcSEcCtD
Esomeprazole—Pruritus—Docetaxel—stomach cancer	3.8e-05	0.000335	CcSEcCtD
Esomeprazole—Nervous system disorder—Methotrexate—stomach cancer	3.8e-05	0.000335	CcSEcCtD
Esomeprazole—Anaemia—Doxorubicin—stomach cancer	3.8e-05	0.000335	CcSEcCtD
Esomeprazole—Thrombocytopenia—Methotrexate—stomach cancer	3.79e-05	0.000335	CcSEcCtD
Esomeprazole—Chest pain—Epirubicin—stomach cancer	3.78e-05	0.000334	CcSEcCtD
Esomeprazole—Myalgia—Epirubicin—stomach cancer	3.78e-05	0.000334	CcSEcCtD
Esomeprazole—Arthralgia—Epirubicin—stomach cancer	3.78e-05	0.000334	CcSEcCtD
Esomeprazole—Agitation—Doxorubicin—stomach cancer	3.77e-05	0.000333	CcSEcCtD
Esomeprazole—Anxiety—Epirubicin—stomach cancer	3.77e-05	0.000332	CcSEcCtD
Esomeprazole—Skin disorder—Methotrexate—stomach cancer	3.76e-05	0.000332	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	3.75e-05	0.000331	CcSEcCtD
Esomeprazole—Hyperhidrosis—Methotrexate—stomach cancer	3.74e-05	0.00033	CcSEcCtD
Esomeprazole—Discomfort—Epirubicin—stomach cancer	3.73e-05	0.00033	CcSEcCtD
Esomeprazole—Asthenia—Capecitabine—stomach cancer	3.73e-05	0.000329	CcSEcCtD
Esomeprazole—Malaise—Doxorubicin—stomach cancer	3.7e-05	0.000327	CcSEcCtD
Esomeprazole—Dry mouth—Epirubicin—stomach cancer	3.7e-05	0.000326	CcSEcCtD
Esomeprazole—Vertigo—Doxorubicin—stomach cancer	3.69e-05	0.000326	CcSEcCtD
Esomeprazole—Anorexia—Methotrexate—stomach cancer	3.69e-05	0.000326	CcSEcCtD
Esomeprazole—Pruritus—Capecitabine—stomach cancer	3.68e-05	0.000325	CcSEcCtD
Esomeprazole—Leukopenia—Doxorubicin—stomach cancer	3.68e-05	0.000325	CcSEcCtD
Esomeprazole—Diarrhoea—Docetaxel—stomach cancer	3.67e-05	0.000324	CcSEcCtD
Esomeprazole—Confusional state—Epirubicin—stomach cancer	3.65e-05	0.000322	CcSEcCtD
Esomeprazole—Palpitations—Doxorubicin—stomach cancer	3.63e-05	0.00032	CcSEcCtD
Esomeprazole—Anaphylactic shock—Epirubicin—stomach cancer	3.62e-05	0.00032	CcSEcCtD
Esomeprazole—CYP3A4—Tryptophan metabolism—ECHS1—stomach cancer	3.6e-05	0.0066	CbGpPWpGaD
Esomeprazole—Infection—Epirubicin—stomach cancer	3.6e-05	0.000318	CcSEcCtD
Esomeprazole—Cough—Doxorubicin—stomach cancer	3.58e-05	0.000316	CcSEcCtD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—stomach cancer	3.57e-05	0.00654	CbGpPWpGaD
Esomeprazole—Shock—Epirubicin—stomach cancer	3.56e-05	0.000315	CcSEcCtD
Esomeprazole—Diarrhoea—Capecitabine—stomach cancer	3.56e-05	0.000314	CcSEcCtD
Esomeprazole—Nervous system disorder—Epirubicin—stomach cancer	3.55e-05	0.000314	CcSEcCtD
Esomeprazole—Dizziness—Docetaxel—stomach cancer	3.55e-05	0.000314	CcSEcCtD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—AKR1C3—stomach cancer	3.55e-05	0.00651	CbGpPWpGaD
Esomeprazole—Thrombocytopenia—Epirubicin—stomach cancer	3.55e-05	0.000313	CcSEcCtD
Esomeprazole—Hypertension—Doxorubicin—stomach cancer	3.55e-05	0.000313	CcSEcCtD
Esomeprazole—Tachycardia—Epirubicin—stomach cancer	3.54e-05	0.000312	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Methotrexate—stomach cancer	3.53e-05	0.000311	CcSEcCtD
Esomeprazole—Skin disorder—Epirubicin—stomach cancer	3.52e-05	0.000311	CcSEcCtD
Esomeprazole—Hyperhidrosis—Epirubicin—stomach cancer	3.5e-05	0.000309	CcSEcCtD
Esomeprazole—Insomnia—Methotrexate—stomach cancer	3.5e-05	0.000309	CcSEcCtD
Esomeprazole—Myalgia—Doxorubicin—stomach cancer	3.5e-05	0.000309	CcSEcCtD
Esomeprazole—Arthralgia—Doxorubicin—stomach cancer	3.5e-05	0.000309	CcSEcCtD
Esomeprazole—Chest pain—Doxorubicin—stomach cancer	3.5e-05	0.000309	CcSEcCtD
Esomeprazole—Anxiety—Doxorubicin—stomach cancer	3.48e-05	0.000308	CcSEcCtD
Esomeprazole—Paraesthesia—Methotrexate—stomach cancer	3.48e-05	0.000307	CcSEcCtD
Esomeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	3.47e-05	0.000307	CcSEcCtD
Esomeprazole—Discomfort—Doxorubicin—stomach cancer	3.45e-05	0.000305	CcSEcCtD
Esomeprazole—Anorexia—Epirubicin—stomach cancer	3.45e-05	0.000305	CcSEcCtD
Esomeprazole—Dyspnoea—Methotrexate—stomach cancer	3.45e-05	0.000305	CcSEcCtD
Esomeprazole—Somnolence—Methotrexate—stomach cancer	3.44e-05	0.000304	CcSEcCtD
Esomeprazole—Dizziness—Capecitabine—stomach cancer	3.44e-05	0.000304	CcSEcCtD
Esomeprazole—Dry mouth—Doxorubicin—stomach cancer	3.42e-05	0.000302	CcSEcCtD
Esomeprazole—Vomiting—Docetaxel—stomach cancer	3.41e-05	0.000301	CcSEcCtD
Esomeprazole—Dyspepsia—Methotrexate—stomach cancer	3.41e-05	0.000301	CcSEcCtD
Esomeprazole—Rash—Docetaxel—stomach cancer	3.39e-05	0.000299	CcSEcCtD
Esomeprazole—Dermatitis—Docetaxel—stomach cancer	3.38e-05	0.000299	CcSEcCtD
Esomeprazole—Confusional state—Doxorubicin—stomach cancer	3.38e-05	0.000298	CcSEcCtD
Esomeprazole—Decreased appetite—Methotrexate—stomach cancer	3.36e-05	0.000297	CcSEcCtD
Esomeprazole—Headache—Docetaxel—stomach cancer	3.36e-05	0.000297	CcSEcCtD
Esomeprazole—Anaphylactic shock—Doxorubicin—stomach cancer	3.35e-05	0.000296	CcSEcCtD
Esomeprazole—Gastrointestinal disorder—Methotrexate—stomach cancer	3.34e-05	0.000295	CcSEcCtD
Esomeprazole—Fatigue—Methotrexate—stomach cancer	3.34e-05	0.000295	CcSEcCtD
Esomeprazole—Infection—Doxorubicin—stomach cancer	3.33e-05	0.000294	CcSEcCtD
Esomeprazole—Pain—Methotrexate—stomach cancer	3.31e-05	0.000292	CcSEcCtD
Esomeprazole—Vomiting—Capecitabine—stomach cancer	3.31e-05	0.000292	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Epirubicin—stomach cancer	3.3e-05	0.000291	CcSEcCtD
Esomeprazole—Shock—Doxorubicin—stomach cancer	3.3e-05	0.000291	CcSEcCtD
Esomeprazole—Nervous system disorder—Doxorubicin—stomach cancer	3.29e-05	0.00029	CcSEcCtD
Esomeprazole—Thrombocytopenia—Doxorubicin—stomach cancer	3.28e-05	0.00029	CcSEcCtD
Esomeprazole—Rash—Capecitabine—stomach cancer	3.28e-05	0.000289	CcSEcCtD
Esomeprazole—Insomnia—Epirubicin—stomach cancer	3.28e-05	0.000289	CcSEcCtD
Esomeprazole—Dermatitis—Capecitabine—stomach cancer	3.28e-05	0.000289	CcSEcCtD
Esomeprazole—Tachycardia—Doxorubicin—stomach cancer	3.27e-05	0.000289	CcSEcCtD
Esomeprazole—Headache—Capecitabine—stomach cancer	3.26e-05	0.000288	CcSEcCtD
Esomeprazole—Skin disorder—Doxorubicin—stomach cancer	3.26e-05	0.000287	CcSEcCtD
Esomeprazole—Paraesthesia—Epirubicin—stomach cancer	3.25e-05	0.000287	CcSEcCtD
Esomeprazole—Hyperhidrosis—Doxorubicin—stomach cancer	3.24e-05	0.000286	CcSEcCtD
Esomeprazole—Dyspnoea—Epirubicin—stomach cancer	3.23e-05	0.000285	CcSEcCtD
Esomeprazole—Somnolence—Epirubicin—stomach cancer	3.22e-05	0.000284	CcSEcCtD
Esomeprazole—CYP3A4—Estrogen metabolism—GSTM1—stomach cancer	3.2e-05	0.00587	CbGpPWpGaD
Esomeprazole—Anorexia—Doxorubicin—stomach cancer	3.19e-05	0.000282	CcSEcCtD
Esomeprazole—Nausea—Docetaxel—stomach cancer	3.19e-05	0.000282	CcSEcCtD
Esomeprazole—Feeling abnormal—Methotrexate—stomach cancer	3.19e-05	0.000282	CcSEcCtD
Esomeprazole—Dyspepsia—Epirubicin—stomach cancer	3.19e-05	0.000282	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Methotrexate—stomach cancer	3.16e-05	0.000279	CcSEcCtD
Esomeprazole—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	3.15e-05	0.00578	CbGpPWpGaD
Esomeprazole—Decreased appetite—Epirubicin—stomach cancer	3.15e-05	0.000278	CcSEcCtD
Esomeprazole—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—stomach cancer	3.14e-05	0.00575	CbGpPWpGaD
Esomeprazole—Gastrointestinal disorder—Epirubicin—stomach cancer	3.13e-05	0.000276	CcSEcCtD
Esomeprazole—Fatigue—Epirubicin—stomach cancer	3.12e-05	0.000276	CcSEcCtD
Esomeprazole—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	3.11e-05	0.00571	CbGpPWpGaD
Esomeprazole—Constipation—Epirubicin—stomach cancer	3.1e-05	0.000274	CcSEcCtD
Esomeprazole—Pain—Epirubicin—stomach cancer	3.1e-05	0.000274	CcSEcCtD
Esomeprazole—Nausea—Capecitabine—stomach cancer	3.09e-05	0.000273	CcSEcCtD
Esomeprazole—Urticaria—Methotrexate—stomach cancer	3.07e-05	0.000272	CcSEcCtD
Esomeprazole—Abdominal pain—Methotrexate—stomach cancer	3.06e-05	0.00027	CcSEcCtD
Esomeprazole—Body temperature increased—Methotrexate—stomach cancer	3.06e-05	0.00027	CcSEcCtD
Esomeprazole—Musculoskeletal discomfort—Doxorubicin—stomach cancer	3.05e-05	0.00027	CcSEcCtD
Esomeprazole—Insomnia—Doxorubicin—stomach cancer	3.03e-05	0.000268	CcSEcCtD
Esomeprazole—Paraesthesia—Doxorubicin—stomach cancer	3.01e-05	0.000266	CcSEcCtD
Esomeprazole—Dyspnoea—Doxorubicin—stomach cancer	2.99e-05	0.000264	CcSEcCtD
Esomeprazole—Feeling abnormal—Epirubicin—stomach cancer	2.98e-05	0.000264	CcSEcCtD
Esomeprazole—Somnolence—Doxorubicin—stomach cancer	2.98e-05	0.000263	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.98e-05	0.00546	CbGpPWpGaD
Esomeprazole—Gastrointestinal pain—Epirubicin—stomach cancer	2.96e-05	0.000262	CcSEcCtD
Esomeprazole—Dyspepsia—Doxorubicin—stomach cancer	2.95e-05	0.000261	CcSEcCtD
Esomeprazole—Decreased appetite—Doxorubicin—stomach cancer	2.91e-05	0.000257	CcSEcCtD
Esomeprazole—CYP3A4—Irinotecan Pathway—APC—stomach cancer	2.91e-05	0.00533	CbGpPWpGaD
Esomeprazole—Gastrointestinal disorder—Doxorubicin—stomach cancer	2.89e-05	0.000255	CcSEcCtD
Esomeprazole—Fatigue—Doxorubicin—stomach cancer	2.89e-05	0.000255	CcSEcCtD
Esomeprazole—Urticaria—Epirubicin—stomach cancer	2.88e-05	0.000254	CcSEcCtD
Esomeprazole—Pain—Doxorubicin—stomach cancer	2.87e-05	0.000253	CcSEcCtD
Esomeprazole—Constipation—Doxorubicin—stomach cancer	2.87e-05	0.000253	CcSEcCtD
Esomeprazole—Abdominal pain—Epirubicin—stomach cancer	2.86e-05	0.000253	CcSEcCtD
Esomeprazole—Body temperature increased—Epirubicin—stomach cancer	2.86e-05	0.000253	CcSEcCtD
Esomeprazole—Hypersensitivity—Methotrexate—stomach cancer	2.85e-05	0.000252	CcSEcCtD
Esomeprazole—Asthenia—Methotrexate—stomach cancer	2.78e-05	0.000245	CcSEcCtD
Esomeprazole—Feeling abnormal—Doxorubicin—stomach cancer	2.76e-05	0.000244	CcSEcCtD
Esomeprazole—Gastrointestinal pain—Doxorubicin—stomach cancer	2.74e-05	0.000242	CcSEcCtD
Esomeprazole—Pruritus—Methotrexate—stomach cancer	2.74e-05	0.000242	CcSEcCtD
Esomeprazole—Hypersensitivity—Epirubicin—stomach cancer	2.67e-05	0.000236	CcSEcCtD
Esomeprazole—Urticaria—Doxorubicin—stomach cancer	2.66e-05	0.000235	CcSEcCtD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—HMOX1—stomach cancer	2.65e-05	0.00486	CbGpPWpGaD
Esomeprazole—Abdominal pain—Doxorubicin—stomach cancer	2.65e-05	0.000234	CcSEcCtD
Esomeprazole—Body temperature increased—Doxorubicin—stomach cancer	2.65e-05	0.000234	CcSEcCtD
Esomeprazole—Diarrhoea—Methotrexate—stomach cancer	2.65e-05	0.000234	CcSEcCtD
Esomeprazole—Asthenia—Epirubicin—stomach cancer	2.6e-05	0.000229	CcSEcCtD
Esomeprazole—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	2.58e-05	0.00473	CbGpPWpGaD
Esomeprazole—Pruritus—Epirubicin—stomach cancer	2.56e-05	0.000226	CcSEcCtD
Esomeprazole—Dizziness—Methotrexate—stomach cancer	2.56e-05	0.000226	CcSEcCtD
Esomeprazole—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	2.56e-05	0.00469	CbGpPWpGaD
Esomeprazole—Diarrhoea—Epirubicin—stomach cancer	2.48e-05	0.000219	CcSEcCtD
Esomeprazole—Hypersensitivity—Doxorubicin—stomach cancer	2.47e-05	0.000218	CcSEcCtD
Esomeprazole—Vomiting—Methotrexate—stomach cancer	2.46e-05	0.000217	CcSEcCtD
Esomeprazole—Rash—Methotrexate—stomach cancer	2.44e-05	0.000215	CcSEcCtD
Esomeprazole—Dermatitis—Methotrexate—stomach cancer	2.44e-05	0.000215	CcSEcCtD
Esomeprazole—Headache—Methotrexate—stomach cancer	2.42e-05	0.000214	CcSEcCtD
Esomeprazole—Asthenia—Doxorubicin—stomach cancer	2.4e-05	0.000212	CcSEcCtD
Esomeprazole—Dizziness—Epirubicin—stomach cancer	2.4e-05	0.000212	CcSEcCtD
Esomeprazole—Pruritus—Doxorubicin—stomach cancer	2.37e-05	0.000209	CcSEcCtD
Esomeprazole—Vomiting—Epirubicin—stomach cancer	2.3e-05	0.000203	CcSEcCtD
Esomeprazole—Nausea—Methotrexate—stomach cancer	2.3e-05	0.000203	CcSEcCtD
Esomeprazole—Diarrhoea—Doxorubicin—stomach cancer	2.29e-05	0.000202	CcSEcCtD
Esomeprazole—Rash—Epirubicin—stomach cancer	2.28e-05	0.000202	CcSEcCtD
Esomeprazole—Dermatitis—Epirubicin—stomach cancer	2.28e-05	0.000201	CcSEcCtD
Esomeprazole—Headache—Epirubicin—stomach cancer	2.27e-05	0.0002	CcSEcCtD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—APOA1—stomach cancer	2.26e-05	0.00414	CbGpPWpGaD
Esomeprazole—Dizziness—Doxorubicin—stomach cancer	2.22e-05	0.000196	CcSEcCtD
Esomeprazole—Nausea—Epirubicin—stomach cancer	2.15e-05	0.00019	CcSEcCtD
Esomeprazole—Vomiting—Doxorubicin—stomach cancer	2.13e-05	0.000188	CcSEcCtD
Esomeprazole—Rash—Doxorubicin—stomach cancer	2.11e-05	0.000187	CcSEcCtD
Esomeprazole—Dermatitis—Doxorubicin—stomach cancer	2.11e-05	0.000186	CcSEcCtD
Esomeprazole—Headache—Doxorubicin—stomach cancer	2.1e-05	0.000185	CcSEcCtD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—APOA1—stomach cancer	2.01e-05	0.00369	CbGpPWpGaD
Esomeprazole—Nausea—Doxorubicin—stomach cancer	1.99e-05	0.000176	CcSEcCtD
Esomeprazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	1.9e-05	0.00348	CbGpPWpGaD
Esomeprazole—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	1.87e-05	0.00343	CbGpPWpGaD
Esomeprazole—ATP4B—Transmembrane transport of small molecules—ALB—stomach cancer	1.79e-05	0.00328	CbGpPWpGaD
Esomeprazole—ATP4A—Transmembrane transport of small molecules—ALB—stomach cancer	1.59e-05	0.00292	CbGpPWpGaD
Esomeprazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	1.54e-05	0.00282	CbGpPWpGaD
Esomeprazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	1.38e-05	0.00253	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—GSTT1—stomach cancer	1.37e-05	0.00252	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—CYP2A6—stomach cancer	1.36e-05	0.00249	CbGpPWpGaD
Esomeprazole—CYP2C19—Arachidonic acid metabolism—PTGS2—stomach cancer	1.33e-05	0.00243	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—AKR1C3—stomach cancer	1.3e-05	0.00239	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPAP2A—stomach cancer	1.18e-05	0.00217	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—stomach cancer	9.93e-06	0.00182	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—GSTP1—stomach cancer	9.52e-06	0.00175	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—GSTP1—stomach cancer	9.39e-06	0.00172	CbGpPWpGaD
Esomeprazole—CYP2C19—Biological oxidations—GSTM1—stomach cancer	8.75e-06	0.0016	CbGpPWpGaD
Esomeprazole—CYP2C19—Metapathway biotransformation—GSTM1—stomach cancer	8.63e-06	0.00158	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GSTT1—stomach cancer	8.26e-06	0.00151	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ACAD8—stomach cancer	8.19e-06	0.0015	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	8.17e-06	0.0015	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ECHS1—stomach cancer	8e-06	0.00147	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	7.84e-06	0.00144	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	7.52e-06	0.00138	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GMPR2—stomach cancer	7.3e-06	0.00134	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	7.05e-06	0.00129	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—RORA—stomach cancer	6.96e-06	0.00128	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SUCLG1—stomach cancer	6.68e-06	0.00122	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—IDH3B—stomach cancer	6.68e-06	0.00122	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NDUFV1—stomach cancer	6.21e-06	0.00114	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NDUFS1—stomach cancer	6.21e-06	0.00114	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	6.07e-06	0.00111	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GSTP1—stomach cancer	5.73e-06	0.00105	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	5.65e-06	0.00104	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—BLVRB—stomach cancer	5.53e-06	0.00101	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PGLS—stomach cancer	5.53e-06	0.00101	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPAP2A—stomach cancer	5.28e-06	0.000967	CbGpPWpGaD
Esomeprazole—CYP3A4—Biological oxidations—GSTM1—stomach cancer	5.26e-06	0.000965	CbGpPWpGaD
Esomeprazole—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	5.19e-06	0.000952	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	5.07e-06	0.00093	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ACAD8—stomach cancer	4.92e-06	0.000903	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NDUFA2—stomach cancer	4.7e-06	0.000862	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CKB—stomach cancer	4.7e-06	0.000862	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—FBP1—stomach cancer	4.7e-06	0.000862	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CA1—stomach cancer	4.7e-06	0.000862	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLIN2—stomach cancer	4.42e-06	0.000811	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GMPR2—stomach cancer	4.39e-06	0.000805	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CA2—stomach cancer	4.3e-06	0.000789	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PGAM1—stomach cancer	4.19e-06	0.000769	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NT5E—stomach cancer	4.19e-06	0.000769	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SUCLG1—stomach cancer	4.01e-06	0.000736	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—IDH3B—stomach cancer	4.01e-06	0.000736	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALDH7A1—stomach cancer	4e-06	0.000733	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PLCE1—stomach cancer	4e-06	0.000733	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—UMPS—stomach cancer	3.83e-06	0.000703	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NDUFV1—stomach cancer	3.73e-06	0.000684	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NDUFS1—stomach cancer	3.73e-06	0.000684	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PDHA1—stomach cancer	3.56e-06	0.000653	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ECHS1—stomach cancer	3.56e-06	0.000653	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—FADS1—stomach cancer	3.35e-06	0.000614	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TYMP—stomach cancer	3.35e-06	0.000614	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PGLS—stomach cancer	3.33e-06	0.00061	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—BLVRB—stomach cancer	3.33e-06	0.00061	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPAP2A—stomach cancer	3.17e-06	0.000582	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—SREBF2—stomach cancer	3.14e-06	0.000575	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—RORA—stomach cancer	3.1e-06	0.000568	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALDOB—stomach cancer	2.91e-06	0.000533	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CKB—stomach cancer	2.83e-06	0.000519	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CA1—stomach cancer	2.83e-06	0.000519	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—FBP1—stomach cancer	2.83e-06	0.000519	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NDUFA2—stomach cancer	2.83e-06	0.000519	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.74e-06	0.000502	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.73e-06	0.000501	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALOX5—stomach cancer	2.7e-06	0.000495	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLIN2—stomach cancer	2.66e-06	0.000488	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—DPYD—stomach cancer	2.66e-06	0.000487	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CA2—stomach cancer	2.59e-06	0.000474	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NT5E—stomach cancer	2.52e-06	0.000462	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PGAM1—stomach cancer	2.52e-06	0.000462	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	2.41e-06	0.000442	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.4e-06	0.000441	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PLCE1—stomach cancer	2.4e-06	0.000441	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTT1—stomach cancer	2.35e-06	0.000431	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CYP2A6—stomach cancer	2.32e-06	0.000426	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—UMPS—stomach cancer	2.31e-06	0.000423	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—AKR1C3—stomach cancer	2.26e-06	0.000414	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ENO1—stomach cancer	2.2e-06	0.000404	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—ALB—stomach cancer	2.17e-06	0.000397	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PDHA1—stomach cancer	2.14e-06	0.000393	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ECHS1—stomach cancer	2.14e-06	0.000393	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—FADS1—stomach cancer	2.02e-06	0.000369	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TYMP—stomach cancer	2.02e-06	0.000369	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CD44—stomach cancer	1.95e-06	0.000358	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—stomach cancer	1.89e-06	0.000347	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—SREBF2—stomach cancer	1.89e-06	0.000346	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—RORA—stomach cancer	1.86e-06	0.000342	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALDOB—stomach cancer	1.75e-06	0.00032	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPP2R1A—stomach cancer	1.66e-06	0.000304	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTP1—stomach cancer	1.63e-06	0.000299	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALOX5—stomach cancer	1.62e-06	0.000298	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—HMOX1—stomach cancer	1.61e-06	0.000295	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—DPYD—stomach cancer	1.6e-06	0.000293	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—TYMS—stomach cancer	1.51e-06	0.000278	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—GSTM1—stomach cancer	1.5e-06	0.000274	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTT1—stomach cancer	1.41e-06	0.000259	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ERCC2—stomach cancer	1.41e-06	0.000258	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.4e-06	0.000256	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.36e-06	0.000249	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ENO1—stomach cancer	1.32e-06	0.000243	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—MTHFR—stomach cancer	1.32e-06	0.000243	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—CAV1—stomach cancer	1.22e-06	0.000224	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—APOA1—stomach cancer	1.22e-06	0.000223	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CD44—stomach cancer	1.17e-06	0.000215	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	1.17e-06	0.000214	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PPARG—stomach cancer	1.07e-06	0.000197	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPP2R1A—stomach cancer	9.99e-07	0.000183	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTP1—stomach cancer	9.79e-07	0.00018	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—HMOX1—stomach cancer	9.66e-07	0.000177	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—ALB—stomach cancer	9.65e-07	0.000177	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—NOS3—stomach cancer	9.23e-07	0.000169	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—TYMS—stomach cancer	9.11e-07	0.000167	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—GSTM1—stomach cancer	9e-07	0.000165	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ERCC2—stomach cancer	8.46e-07	0.000155	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PTGS2—stomach cancer	8.44e-07	0.000155	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—MTHFR—stomach cancer	7.95e-07	0.000146	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—CAV1—stomach cancer	7.34e-07	0.000135	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—APOA1—stomach cancer	7.32e-07	0.000134	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PPARG—stomach cancer	6.45e-07	0.000118	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—ALB—stomach cancer	5.8e-07	0.000106	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—NOS3—stomach cancer	5.55e-07	0.000102	CbGpPWpGaD
Esomeprazole—CYP2C19—Metabolism—PIK3CA—stomach cancer	5.19e-07	9.52e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PTGS2—stomach cancer	5.07e-07	9.3e-05	CbGpPWpGaD
Esomeprazole—CYP3A4—Metabolism—PIK3CA—stomach cancer	3.12e-07	5.72e-05	CbGpPWpGaD
